levetiracetam low dose (AGB101) - AgeneBio
Revlimid (lenalidomide) - BMS
Decadron (dexamethasone) - Merck (MSD)
ciltacabtagene autoleucel (LCAR-B38M) - J&J
Cyrevia (cyclophosphamide high dose) - Accentia
https://www.oncnursingnews.com/view/prompt-treatment-of-car-t-cell-therapy-related-aes-can-prevent-long-term-lasting-effects
 
Jul 5, 2021
 
Prev Next